Stay updated with breaking news from Nature Methods. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kelonia Therapeutics is developing cell therapies made by the in vivo engineering of a patient’s cells made possible by the targeted delivery of a genetic payload. The startup, newly out of stealth with $50M in funding, claims its approach would offer manufacturing and safety advantages over other cell therapy technologies.
In the characterization of nanoparticles, researchers at the Max Planck Institute for the Science of Light (MPL) and Max-Planck-Zentrum für Physik und Medizin (MPZPM) in Erlangen have made a substantial step forward.
10x Genomics, Inc. (NASDAQ:NASDAQ:TXG) Q1 2022 Earnings Conference Call May 04, 2022 04:30 PM ET Company Participants Cassie Corneau - Investor Relations and Strategic Finance Serge Saxonov...
Job: Postdoc Fellow at Massachusetts General Hospital/Harvard Medical School - Martinos Center for Biomedical Imaging at MGH/HMS Charlestown, MA, United States
A new method for monitoring proteins could lead to better drug development